NCT02466984View on ClinicalTrials.gov

Subcutaneous Route and Pharmacology of Metoclopramide

PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2019

Conditions
NauseaVomiting
Interventions
DRUG

metoclopramide intravenous

Administration route

Trial Locations (1)

33000

Centre Hospitalier Universitaire de Bordeaux - St André, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02466984 - Subcutaneous Route and Pharmacology of Metoclopramide | Biotech Hunter | Biotech Hunter